LVZPF Stock - Livzon Pharmaceutical Group Inc.
Unlock GoAI Insights for LVZPF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $11.81B | $12.43B | $12.63B | $12.06B | $10.52B |
| Gross Profit | $7.73B | $7.66B | $8.17B | $7.81B | $6.85B |
| Gross Margin | 65.5% | 61.6% | 64.7% | 64.7% | 65.1% |
| Operating Income | $2.84B | $2.42B | $2.35B | $2.27B | $2.50B |
| Net Income | $2.06B | $1.95B | $1.91B | $1.78B | $1.71B |
| Net Margin | 17.4% | 15.7% | 15.1% | 14.7% | 16.3% |
| EPS | $2.24 | $2.10 | $2.04 | $1.90 | $1.83 |
Livzon Pharmaceutical Group Inc. engages in the research, development, production, and sale of pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People's Republic of China. The company offers Ilaprazole enteric coated tablets for the treatment of duodenal ulcers and reflux esophagitis; Laprazole sodium for injection to treat peptic ulcer hemorrhage; Leuprorelin Acetate Microspheres for injection; Urofollitropin for injection to treat anovulation and sufferers; Perospirone Hydrochloride for the treatment of schizophrenia; Anti-viral Granules to treat upper respiratory tract infection and influenza; and Shenqi Fuzheng Injection for the treatment of weakness and tiredness, lassitude, spontaneous sweating, and vertigo, as well as for the patients of lung and stomach cancer. It also offers diagnostic reagents, such as diagnostic kit for IgM/IgG antibody to coronavirus; nucleic acid test kit for human immunodeficiency virus type 1; antinuclear antibody test kits; interferon-gamma release assays test kits; and rapid test for mycoplasma pneumoniae IgM antibody. In addition, the company provides biochemical drugs, microbiological preparations, biologic products, Chinese drug preparations and pharmaceutical raw materials, and antibiotics. It also exports its products. The company was founded in 1985 and is headquartered in Zhuhai, China.
Visit WebsiteEarnings History & Surprises
LVZPFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 21, 2026 | — | — | — | — |
Q4 2025 | Oct 23, 2025 | $0.08 | $0.01 | -87.4% | ✗ MISS |
Q2 2025 | Apr 21, 2025 | $0.10 | $0.10 | +1.1% | ✓ BEAT |
Q4 2024 | Dec 31, 2024 | — | $0.06 | — | — |
Q4 2024 | Oct 23, 2024 | $0.08 | $0.08 | -4.1% | ✗ MISS |
Q3 2024 | Aug 22, 2024 | $0.08 | $0.08 | +10.8% | ✓ BEAT |
Q2 2024 | Apr 23, 2024 | $0.08 | $0.09 | +11.3% | ✓ BEAT |
Q1 2024 | Jan 12, 2024 | — | $0.05 | — | — |
Q3 2023 | Sep 30, 2023 | $0.08 | $0.07 | -17.8% | ✗ MISS |
Q2 2023 | Jun 30, 2023 | $0.08 | $0.08 | -2.7% | ✗ MISS |
Q1 2023 | Mar 30, 2023 | $0.06 | $0.06 | +7.5% | ✓ BEAT |
Q4 2022 | Dec 31, 2022 | — | $0.06 | — | — |
Q4 2022 | Oct 25, 2022 | $0.07 | $0.07 | +2.0% | ✓ BEAT |
Q3 2022 | Aug 9, 2022 | $0.09 | $0.07 | -16.7% | ✗ MISS |
Q2 2022 | Apr 21, 2022 | $0.10 | $0.09 | -10.6% | ✗ MISS |
Q4 2021 | Dec 31, 2021 | — | $0.05 | — | — |
Q4 2021 | Oct 25, 2021 | $0.10 | $0.06 | -38.8% | ✗ MISS |
Q3 2021 | Aug 24, 2021 | $0.09 | $0.09 | 0.0% | = MET |
Q2 2021 | Apr 21, 2021 | $0.10 | $0.08 | -15.4% | ✗ MISS |
Q4 2020 | Dec 31, 2020 | — | $0.05 | — | — |
Latest News
Frequently Asked Questions about LVZPF
What is LVZPF's current stock price?
What is the analyst price target for LVZPF?
What sector is Livzon Pharmaceutical Group Inc. in?
What is LVZPF's market cap?
Does LVZPF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to LVZPF for comparison